Literature DB >> 21900616

Contrast-enhanced MR angiography of the abdomen with highly accelerated acquisition techniques.

Petrice M Mostardi1, James F Glockner, Phillip M Young, Stephen J Riederer.   

Abstract

PURPOSE: To demonstrate that highly accelerated (net acceleration factor [R(net)] ≥ 10) acquisition techniques can be used to generate three-dimensional (3D) subsecond timing images, as well as diagnostic-quality high-spatial-resolution contrast material-enhanced (CE) renal magnetic resonance (MR) angiograms with a single split dose of contrast material.
MATERIALS AND METHODS: All studies were approved by the institutional review board and were HIPAA compliant; written consent was obtained from all participants. Twenty-two studies were performed in 10 female volunteers (average age, 47 years; range, 27-62 years) and six patients with renovascular disease (three women; average age, 48 years; range, 37-68 years; three men; average age, 60 years; range, 50-67 years; composite average age, 54 years; range, 38-68 years). The two-part protocol consisted of a low-dose (2 mL contrast material) 3D timing image with approximate 1-second frame time, followed by a high-spatial-resolution (1.0-1.6-mm isotropic voxels) breath-hold 3D renal MR angiogram (18 mL) over the full abdominal field of view. Both acquisitions used two-dimensional (2D) sensitivity encoding acceleration factor (R) of eight and 2D homodyne (HD) acceleration (R(HD)) of 1.4-1.8 for R(net) = R · R(HD) of 10 or higher. Statistical analysis included determination of mean values and standard deviations of image quality scores performed by two experienced reviewers with use of eight evaluation criteria.
RESULTS: The 2-mL 3D time-resolved image successfully portrayed progressive arterial filling in all 22 studies and provided an anatomic overview of the vasculature. Successful timing was also demonstrated in that the renal MR angiogram showed adequate or excellent portrayal of the main renal arteries in 21 of 22 studies.
CONCLUSION: Two-dimensional acceleration techniques with R(net) of 10 or higher can be used in CE MR angiography to acquire (a) a 3D image series with 1-second frame time, allowing accurate bolus timing, and (b) a high-spatial-resolution renal angiogram. SUPPLEMENTAL MATERIAL: http://radiology.rsna.org/lookup/suppl/doi:10.1148/radiol.11110242/-/DC1. RSNA, 2011

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21900616      PMCID: PMC3198221          DOI: 10.1148/radiol.11110242

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  36 in total

1.  Renal arteries: optimization of three-dimensional gadolinium-enhanced MR angiography with bolus-timing-independent fast multiphase acquisition in a single breath hold.

Authors:  S O Schoenberg; M Bock; M V Knopp; M Essig; G Laub; H Hawighorst; I Zuna; F Kallinowski; G van Kaick
Journal:  Radiology       Date:  1999-06       Impact factor: 11.105

2.  Generalized autocalibrating partially parallel acquisitions (GRAPPA).

Authors:  Mark A Griswold; Peter M Jakob; Robin M Heidemann; Mathias Nittka; Vladimir Jellus; Jianmin Wang; Berthold Kiefer; Axel Haase
Journal:  Magn Reson Med       Date:  2002-06       Impact factor: 4.668

3.  Thorax: low-dose contrast-enhanced three-dimensional MR angiography with subsecond temporal resolution--initial results.

Authors:  J Paul Finn; Visveshwar Baskaran; James C Carr; Richard M McCarthy; F Scott Pereles; Randall Kroeker; Gerhard A Laub
Journal:  Radiology       Date:  2002-09       Impact factor: 11.105

4.  Sensitivity encoding (SENSE) for contrast-enhanced 3D MR angiography of the abdominal arteries.

Authors:  Markus Born; Winfried A Willinek; Jürgen Gieseke; Marcus von Falkenhausen; Hans Schild; Christiane K Kuhl
Journal:  J Magn Reson Imaging       Date:  2005-10       Impact factor: 4.813

5.  High-resolution renal MRA: comparison of image quality and vessel depiction with different parallel imaging acceleration factors.

Authors:  Henrik J Michaely; Karin A Herrmann; Harald Kramer; Olaf Dietrich; Gerhard Laub; Maximilian F Reiser; Stefan O Schoenberg
Journal:  J Magn Reson Imaging       Date:  2006-07       Impact factor: 4.813

6.  Low-dose, time-resolved, contrast-enhanced 3D MR angiography in cardiac and vascular diseases: correlation to high spatial resolution 3D contrast-enhanced MRA.

Authors:  M S Krishnam; A Tomasian; D G Lohan; L Tran; J P Finn; S G Ruehm
Journal:  Clin Radiol       Date:  2008-03-28       Impact factor: 2.350

7.  The effects of incomplete breath-holding on 3D MR image quality.

Authors:  J H Maki; T L Chenevert; M R Prince
Journal:  J Magn Reson Imaging       Date:  1997 Nov-Dec       Impact factor: 4.813

8.  Contrast-enhanced abdominal MR angiography: optimization of imaging delay time by automating the detection of contrast material arrival in the aorta.

Authors:  M R Prince; T L Chenevert; T K Foo; F J Londy; J S Ward; J H Maki
Journal:  Radiology       Date:  1997-04       Impact factor: 11.105

9.  Peripheral vasculature: high-temporal- and high-spatial-resolution three-dimensional contrast-enhanced MR angiography.

Authors:  Clifton R Haider; James F Glockner; Anthony W Stanson; Stephen J Riederer
Journal:  Radiology       Date:  2009-09-29       Impact factor: 11.105

10.  Isotropic high-spatial-resolution contrast-enhanced 3.0-T MR angiography in patients suspected of having renal artery stenosis.

Authors:  Ulrich Kramer; Jakub Wiskirchen; Michael C Fenchel; Achim Seeger; Gerhard Laub; Gunnar Tepe; J Paul Finn; Claus D Claussen; Stephan Miller
Journal:  Radiology       Date:  2008-02-12       Impact factor: 11.105

View more
  8 in total

1.  Recent advances in 3D time-resolved contrast-enhanced MR angiography.

Authors:  Stephen J Riederer; Clifton R Haider; Eric A Borisch; Paul T Weavers; Phillip M Young
Journal:  J Magn Reson Imaging       Date:  2015-06-01       Impact factor: 4.813

2.  Selection and evaluation of optimal two-dimensional CAIPIRINHA kernels applied to time-resolved three-dimensional CE-MRA.

Authors:  Paul T Weavers; Eric A Borisch; Stephen J Riederer
Journal:  Magn Reson Med       Date:  2014-07-15       Impact factor: 4.668

3.  High temporal and spatial resolution imaging of peripheral vascular malformations.

Authors:  Petrice M Mostardi; Phillip M Young; Michael A McKusick; Stephen J Riederer
Journal:  J Magn Reson Imaging       Date:  2012-06-04       Impact factor: 4.813

4.  Acceleration apportionment: a method of improved 2D SENSE acceleration applied to 3D contrast-enhanced MR angiography.

Authors:  Paul T Weavers; Eric A Borisch; Casey P Johnson; Stephen J Riederer
Journal:  Magn Reson Med       Date:  2014-02       Impact factor: 4.668

5.  Vascular masking for improved unfolding in 2D SENSE-accelerated 3D contrast-enhanced MR angiography.

Authors:  Eric G Stinson; Eric A Borisch; Casey P Johnson; Joshua D Trzasko; Phillip M Young; Stephen J Riederer
Journal:  J Magn Reson Imaging       Date:  2013-07-29       Impact factor: 4.813

6.  Improved receiver arrays and optimized parallel imaging accelerations applied to time-resolved 3D fluoroscopically tracked peripheral runoff CE-MRA.

Authors:  Paul T Weavers; Eric A Borisch; Tom C Hulshizer; Phillip J Rossman; Phillip M Young; Casey P Johnson; Jessica McKay; Christopher C Cline; Stephen J Riederer
Journal:  Magn Reson Imaging       Date:  2015-10-31       Impact factor: 2.546

7.  Evaluation of quantitative parameters of dynamic contrast-enhanced magnetic resonance imaging in qualitative diagnosis of hepatic masses.

Authors:  Jingjing Chen; Youjiao Si; Kaikai Zhao; Xianglong Shi; Weiqun Bi; Shi-En Liu; Hui Hua
Journal:  BMC Med Imaging       Date:  2018-12-27       Impact factor: 1.930

8.  High Acceleration Three-Dimensional T1-Weighted Dual Echo Dixon Hepatobiliary Phase Imaging Using Compressed Sensing-Sensitivity Encoding: Comparison of Image Quality and Solid Lesion Detectability with the Standard T1-Weighted Sequence.

Authors:  Ju Gang Nam; Jeong Min Lee; Sang Min Lee; Hyo Jin Kang; Eun Sun Lee; Bo Yun Hur; Jeong Hee Yoon; EunJu Kim; Mariya Doneva
Journal:  Korean J Radiol       Date:  2019-03       Impact factor: 3.500

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.